The Quantellect read.As of Nov 19, 2026, 11 active firms cover Exelixis Inc: 3 rate it Buy or better, 8 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $49.00 to $65.00, so the covering firms are broadly aligned. The average target of $53.55 sits 22% below the current $68.27. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.88 next quarter toward $4.27 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 active firms
Neutral
Strong Buy00%
Buy327%
Neutral873%
Sell00%
Strong Sell00%
Based on 11 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$53.55
-21.6% downside
Average target across 11 active firms as of Nov 19, 2026 vs $68.27 current
Highest Target$65.00
Average Target$53.55
Lowest Target$49.00
Detailed analyst forecasts for EXEL
Showing 1–11 of 11 named analysts shown · 11 active firms in the rating projection
As of Nov 19, 2026, 3 of 11 active firms rate EXEL a Buy (8 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
EXEL EPS & revenue forecast
EPS · NEXT QUARTER
$0.88
Range $0.82 – $0.94 · 2 analysts · +1% YoY
Next period, 2 analysts expect Exelixis Inc to earn $0.88 a share (range $0.82 – $0.94), versus $0.87 a year earlier. Full-year consensus is $3.75, growing to $4.27 the year after.
REVENUE · NEXT QUARTER
$690.8M
Range $670.0M – $722.1M · 2 analysts · +13% YoY
Revenue is expected to reach $690.8M (range $670.0M – $722.1M), +13.1% year-over-year. Full-year consensus is $2.6B, rising to $2.9B next year.
Top analysts covering Exelixis Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EXEL.
#1
Michael Schmidt
Guggenheim · Rank #4
Neutral
No targeton EXEL
Overall win rate
53%
+ Follow
#2
Leonid Timashev
RBC Capital · Rank #27
Neutral
$58.00-15.0% to target
Overall win rate
52%
+ Follow
#3
Silvan Tuerkcan
JMP Securities · Rank #69
Buy
$65.00-4.8% to target
Overall win rate
51%
+ Follow
#4
Paul Choi
Goldman Sachs · Rank #110
Buy
$64.00-6.3% to target
Overall win rate
52%
+ Follow
#5
Jason Gerberry
B of A Securities · Rank #160
Sell
$41.00-39.9% to target
Overall win rate
47%
+ Follow
EXEL stock forecast FAQ
What is EXEL's average 12-month price target?+
The 11 active firms with a live target average $53.55 for Exelixis Inc over the next 12 months, ranging from a $65.00 high to a $49.00 low, as of Nov 19, 2026.
Is EXEL stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 11 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 8 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for EXEL?+
The Street-high target is $65.00 (Citizens), and the Street-low is $49.00 (Barclays). The average of all 11 active-firm targets is $53.55.
How many active Wall Street firms cover EXEL?+
11 active firms have a recognized rating on Exelixis Inc as of Nov 19, 2026, and 11 active firms carry a live 12-month price target.
Who is the most accurate analyst covering EXEL?+
Among analysts who currently cover EXEL, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #4). Their current call is Neutral.
What is Exelixis Inc's projected EPS for next quarter?+
The consensus estimate is $0.88 per share (range $0.82 – $0.94) across 2 analysts. Full-year EPS is projected at $3.75, rising to $4.27 the following year.
How much revenue is Exelixis Inc expected to report next quarter?+
Consensus revenue is $690.8M (range $670.0M – $722.1M). Full-year revenue is projected at $2.6B, growing to $2.9B next year.
Have analysts been upgrading or downgrading EXEL lately?+
As of Nov 19, 2026, 3 of 11 active firms rate EXEL a Buy (8 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EXEL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.